NUC-7738 is being explored for its potential in cancer therapy, particularly in targeting hard-to-treat cancers. Its mechanism involves enhancing the delivery and activation of cytotoxic agents within cancer cells, which can improve efficacy while reducing side effects. This compound is currently under clinical investigation, showing promise in overcoming drug resistance and improving patient outcomes in various malignancies. Its application is primarily focused on advancing precision medicine in oncology.